Genomic Data Set for Real World Evidence (RWE) Applications Market Size, Share, By Genomic Data Type (Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES), and Targeted Sequencing), By Data (Structured Data, and Unstructured Data), By Patient Records (Electronic Health Records (EHRs), Claims Data, Patient Reported Outcomes (PROs)), By Application (Oncology, Cardiovascular, Neurology, Immunology, and Others), and Region (North America, Europe, Asia Pacific, Middle East and Africa, and South America) - Trends, Analysis and Forecast till 2034

Report Code: PMI531424 | Publish Date: June 2024 | No. of Pages: 185

Genomic Data Set For Real World Evidence Rwe Applications Market Companies

  • IQVIA Inc
  • TEMPUS
  • LabCorp
  • Invitae Corporation
  • Guardant Health
  • Ovation.io
  • Myriad Genetics Inc.
  • Caris Life Sciences
  • HealthVerity, Inc
  • Foundation Medicine, Inc.
  • Komodo Health, Inc.
  • Natera, Inc

Recent News:

  • In April 2024, Palantir Technologies Inc. and Parexel partnered to leverage AI to expedite and enhance the provision of effective and secure clinical trials for customers in the global biopharmaceutical sector. The collaboration enhanced Paraxel's capabilities in RWE, health outcomes, and advanced analytics, making better clinical trial procedures feasible.
  • In October 2021, The Real-World Data Registry, established by the Real-World Evidence Transparency Initiative, aims to increase transparency in medical research and healthcare by reporting and analyzing real-world data. The International Society for Pharmacoepidemiology, the National Pharmaceutical Council, the Duke-Margolis Centre for Health Policy, and ISPOR collaborated to create the Real-World Evidence Transparency Initiative.